Please Wait
Applying Filters...
menu
    • menu
    Pfanstiehl, a global leader in the manufacture of cGMP high purity, low endotoxin, low metals (HPLE-LM)TM injectable grade excipients.

    Virtual Booth

    Contact Supplier

    Faran Shimi: Leading producer of high-quality APIs & alkaloid opiates, serving major pharmaceutical companies across the Middle East.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2025-01-27

    Virtual Booth

    Contact Supplier

    Sharp is a global leader in pharmaceutical packaging and clinical trial supply services.

    Virtual Booth

    Contact Supplier

    FAMAR CDMO- From early development to commercial manufacturing.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2025-01-20

    Virtual Booth

    Contact Supplier

    Menu

    Ciforadenant

    DEVELOPMENTS

    DIGITAL CONTENT

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Corvus Presents Ciforadenant Data in Prostate Cancer
    Corvus Presents Ciforadenant Data in Prostate Cancer

    09 Nov 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2024/11/09/2977967/0/en/Corvus-Pharmaceuticals-Announces-New-Data-Highlighting-Potential-of-Ciforadenant-to-Overcome-Immunotherapy-Resistance-in-Metastatic-Castration-Resistant-Prostate-Cancer.html

    GLOBENEWSWIRE
    09 Nov 2024
    Share Share
    Corvus Pharma Announces Initiation of Phase 1b/2 Clinical Trial of Ciforadenant
    Corvus Pharma Announces Initiation of Phase 1b/2 Clinical Trial of Ciforadenant

    25 Oct 2022

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2022/10/25/2541307/0/en/Corvus-Pharmaceuticals-Announces-Initiation-of-Phase-1b-2-Clinical-Trial-of-Ciforadenant-as-Potential-First-Line-Treatment-for-Patients-with-Renal-Cell-Cancer.html

    GLOBENEWSWIRE
    25 Oct 2022
    Share Share
    Corvus to Present Data on Refinement of the Adenosine Gene Signature
    Corvus to Present Data on Refinement of the Adenosine Gene Signature

    13 May 2020

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2020/05/13/2033077/0/en/Corvus-Pharmaceuticals-to-Present-Data-on-Refinement-of-the-Adenosine-Gene-Signature-and-Ciforadenant-in-Renal-Cell-Cancer-at-the-ASCO20-Virtual-Scientific-Program.html

    GLOBENEWSWIRE
    13 May 2020
    Share Share